Cellid (299660.KQ) Financials

299660.KQ Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 51.3 billion 21.3 billion
2023-06-30 31.0 billion 15.6 billion
2023-03-31 34.9 billion 15.9 billion
2022-12-31 45.9 billion 23.4 billion

299660.KQ Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.5 billion 413.0 million
2023-06-30 -3.7 billion 73.7 million
2023-03-31 -1.7 billion 99.5 million
2022-12-31 -2.8 billion 90.2 million

299660.KQ Net Income

No data available :(

299660.KQ Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - 15.2 million
2023-06-30 8.0 billion - 23.8 million
2023-03-31 9.3 billion 4.5 million 34.1 million
2022-12-31 18.7 billion 8.9 million 52.3 million

299660.KQ Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 13.6 million
2023-06-30 11.1 million
2023-03-31 11.1 million
2022-12-31 11.1 million

299660.KQ Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4.9 billion 832.3 million 466.1 million -
2023-06-30 863.8 million 1.8 billion 1.2 billion -
2023-03-31 35.5 million 1.4 billion 1.3 billion -
2022-12-31 1.2 billion 694.2 million 1.2 billion -

299660.KQ Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 480.0 million 324.5 million

299660.KQ

Price: ₩3,670

52 week price:
3100.00
9370.00

Exchange: KOE

Sector: Health Technology

Industry: Pharmaceuticals: Major

Market Capitalization: 52.2 billion

Links: